RxDoctor Payments DataLook up a doctor →

Christine Moore, DO

Family Medicine · Raymore, MONPI 1235131574

Payments from drug & device makers

$57,133in general payments, 2019–2025

Across 1,093 payments — averaging $52.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$31K
  • Otsuka America Pharmaceutical, Inc.$13K
  • Pfizer$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Boehringer Ingelheim$628
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)214$31,219
Otsuka America Pharmaceutical, Inc.74$12,549
Pfizer110$1,408
AstraZeneca68$1,401
Lilly USA, LLC75$1,142
Boehringer Ingelheim41$628
Merck46$612
Amgen31$584
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)26$566
Novo Nordisk33$452
Lundbeck LLC24$440
Supernus Pharmaceuticals, Inc.28$413
Antares Pharma, Inc.23$361
GSK21$348
Collegium Pharmaceutical, Inc.18$326
Takeda Pharmaceuticals U.S.A., Inc.20$302
Axsome Therapeutics, Inc.13$275
Teva Pharmaceuticals USA, Inc.17$256
Abbott7$232
Bayer14$221
Biohaven Pharmaceutical Holding Company Ltd.12$203
Novartis13$198
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$170
Medtronic(2 entities)3$138
Scilex Pharmaceuticals Inc.7$121
Kowa Pharmaceuticals America, Inc.9$120
Amarin Pharma, Inc.7$110
Sunovion Pharmaceuticals Inc.8$105
Ironwood Pharmaceuticals, Inc7$103
Comsort, Inc1$100
Dexcom, Inc.6$100
Sanofi3$95
Ardelyx, Inc.4$94
E.r. Squibb & Sons, L.L.C.5$91
Vanda Pharmaceuticals Inc.3$88
Johnson & Johnson6$87
Sanofi-aventis U.S. LLC4$81
Nevro Corp.3$77
Almatica Pharma LLC4$76
Mannkind Corporation4$74
Sumitomo Pharma America, Inc.4$74
Astellas Pharma US Inc4$71
Biohaven Pharmaceuticals, Inc.4$71
Corium, LLC3$66
Mylan Specialty L.p.5$63
Eisai Inc.4$54
Ironshore Pharmaceuticals Inc.3$51
Vifor Pharma, Inc.2$45
Arbor Pharmaceuticals, Inc.3$41
Globus Medical2$41
Insulet Corporation2$41
UCB, Inc.2$40
Idorsia Pharmaceuticals US Inc2$38
Daiichi Sankyo Inc.2$36
Halozyme Inc2$31
Clarus Therapeutics Inc.2$29
Esperion Therapeutics, Inc.2$29
Shire North American Group Inc2$28
IBSA Pharma Inc.2$26
Biodelivery Sciences International, Inc.2$24

How this compares

$57,133 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$75,137
Medicare patients
276
Services billed
938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Raymore

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →